Aberdeen Group’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.9M | Sell |
255,248
-13,262
| -5% | -$813K | 0.02% | 553 |
|
|
2026
Q1 | $17.5M | Buy |
268,510
+5,223
| +2% | +$382K | 0.03% | 460 |
|
|
2025
Q4 | $21.2M | Buy |
263,287
+30,723
| +13% | +$2.47M | 0.03% | 407 |
|
|
2025
Q3 | $19.1M | Buy |
232,564
+431
| +0.2% | +$37.4K | 0.03% | 450 |
|
|
2025
Q2 | $21.2M | Sell |
232,133
-162,390
| -41% | -$14.5M | 0.04% | 394 |
|
|
2025
Q1 | $36.1M | Sell |
394,523
-33,437
| -8% | -$2.92M | 0.07% | 241 |
|
|
2024
Q4 | $36.4M | Sell |
427,960
-26,333
| -6% | -$2.31M | 0.07% | 259 |
|
|
2024
Q3 | $39.5M | Sell |
454,293
-162,022
| -26% | -$13.6M | 0.07% | 251 |
|
|
2024
Q2 | $48.6M | Sell |
616,315
-16,039
| -3% | -$1.32M | 0.09% | 209 |
|
|
2024
Q1 | $57.1M | Sell |
632,354
-14,451
| -2% | -$1.32M | 0.11% | 193 |
|
|
2023
Q4 | $56.8M | Buy |
646,805
+500
| +0.1% | +$41.7K | 0.12% | 189 |
|
|
2023
Q3 | $54.6M | Buy |
646,305
+65,482
| +11% | +$5.91M | 0.14% | 143 |
|
|
2023
Q2 | $57.4M | Buy |
580,823
+20,461
| +4% | +$1.93M | 0.13% | 154 |
|
|
2023
Q1 | $53.8M | Sell |
560,362
-203,618
| -27% | -$18.8M | 0.13% | 157 |
|
|
2022
Q4 | $69.4M | Buy |
763,980
+126,186
| +20% | +$10.7M | 0.19% | 119 |
|
|
2022
Q3 | $50.7M | Buy |
637,794
+31,309
| +5% | +$2.65M | 0.15% | 142 |
|
|
2022
Q2 | $50.9M | Buy |
606,485
+328,009
| +118% | +$27M | 0.16% | 130 |
|
|
2022
Q1 | $23.1M | Buy |
278,476
+252,284
| +963% | +$19.8M | 0.06% | 285 |
|
|
2021
Q4 | $1.96M | Sell |
26,192
-13
| -0% | -$976 | ﹤0.01% | 781 |
|
|
2021
Q3 | $1.98M | Buy |
26,205
+344
| +1% | +$26.6K | ﹤0.01% | 787 |
|
|
2021
Q2 | $2M | Sell |
25,861
-189
| -0.7% | -$14.6K | ﹤0.01% | 768 |
|
|
2021
Q1 | $1.83M | Sell |
26,050
-1,453
| -5% | -$110K | ﹤0.01% | 773 |
|
|
2020
Q4 | $1.95M | Sell |
27,503
-279,207
| -91% | -$17.5M | ﹤0.01% | 747 |
|
|
2020
Q3 | $17.6M | Buy |
306,710
+78,335
| +34% | +$4.68M | 0.05% | 315 |
|
|
2020
Q2 | $13.9M | Buy |
228,375
+146,867
| +180% | +$9.07M | 0.04% | 355 |
|
|
2020
Q1 | $4.48M | Sell |
81,508
-7,720
| -9% | -$518K | 0.01% | 538 |
|
|
2019
Q4 | $6.44M | Buy |
89,228
+5,011
| +6% | +$341K | 0.02% | 548 |
|
|
2019
Q3 | $5.57M | Buy |
84,217
+42,611
| +102% | +$2.74M | 0.01% | 571 |
|
|
2019
Q2 | $2.58M | Buy |
41,606
+21,799
| +110% | +$1.26M | 0.01% | 709 |
|
|
2019
Q1 | $1.07M | Sell |
19,807
-3,116,348
| -99% | -$175M | ﹤0.01% | 804 |
|
|
2018
Q4 | $183M | Buy |
3,136,155
+65,812
| +2% | +$4.13M | 0.43% | 65 |
|
|
2018
Q3 | $203M | Buy |
3,070,343
+176,096
| +6% | +$11.6M | 0.38% | 72 |
|
|
2018
Q2 | $192M | Buy |
2,894,247
+427,752
| +17% | +$28.8M | 0.37% | 69 |
|
|
2018
Q1 | $165M | Sell |
2,466,495
-26,469
| -1% | -$1.78M | 0.33% | 81 |
|
|
2017
Q4 | $163M | Sell |
2,492,964
-301,213
| -11% | -$19.6M | 0.31% | 83 |
|
|
2017
Q3 | $180M | Buy |
+2,794,177
| New | +$180M | 0.33% | 77 |
|
Other funds holding DOX
BGC
BIP
Aberdeen Group's DOX Position: Q2 2026 in Review
Aberdeen Group reduced its Amdocs (DOX) stake by 4.9% in Q2 2026, selling an estimated $813K and leaving 255,248 shares worth $12.9M. The position accounts for 0.02% of the portfolio, ranked #553.
Aberdeen Group first reported a position in DOX in Q3 2017 and has held it in 36 quarters since. The position peaked at $203M in Q3 2018. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.
- Aberdeen Group held 255,248 shares of Amdocs worth $12.9M as of Q2 2026.
- Aberdeen Group sold 13,262 Amdocs shares in Q2 2026, an estimated $813K.
- Amdocs made up 0.02% of Aberdeen Group's portfolio in Q2 2026, its #553 holding.
- Aberdeen Group first reported a position in Amdocs in Q3 2017 and has held it in 36 quarters since.
- Aberdeen Group's Amdocs position peaked at $203M in Q3 2018.
- 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.